Data as of Aug 16, 2026 · Based on 3,131,739 AI responses across 10,525 prompts · See how Parse measures this
Eversense Continuous Glucose Monitoring is a long-term CGM system with an FDA-approved sensor designed to reduce device-wearing burden and improve clinical outcomes. It is available only for purchase by healthcare providers and features the Eversense 365 system, the first one-year CGM sensor and transmitter kit.
Sources
type1strong.org shapes more of what AI says about Eversense than any other source, at 21% of its citations.
eversensecgm.com · fda.gov · glucoseintel.com · healthline.com
The market map
Continuous Glucose Monitoring Devices →Where AI ranks Eversense
Excerpts where Eversense appeared in the AI's answer

Eversense 365: Best for long-term wear . This is the first long-term implantable CGM system that functions for up to a full year

Eversense 365 lasts up to a year but requires a clinician to implant and remove the sensor.